VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION CAPSULE

Land: Canada

Taal: Engels

Bron: Health Canada

Werkstoffen:

VITAMIN A (RETINYL PALMITATE); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)

Beschikbaar vanaf:

NUTRICORP INTERNATIONAL

ATC-code:

A11JA

INN (Algemene Internationale Benaming):

COMBINATIONS OF VITAMINS

Dosering:

100000UNIT; 20UNIT

farmaceutische vorm:

CAPSULE

Samenstelling:

VITAMIN A (RETINYL PALMITATE) 100000UNIT; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 20UNIT

Toedieningsweg:

ORAL

Eenheden in pakket:

500

Prescription-type:

Prescription

Therapeutisch gebied:

VITAMIN A

Product samenvatting:

Active ingredient group (AIG) number: 0225696006; AHFS:

Autorisatie-status:

APPROVED

Autorisatie datum:

2016-04-06

Productkenmerken

_ _
_Page 1 of 34_
PRODUCT MONOGRAPH
PR
VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION
VITAMIN A AND VITAMIN E SOFTGEL CAPSULES
100,000 IU Vitamin A (all-trans-retinyl palmitate) and 20 IU Vitamin E
(all-rac-alpha-
tocopheryl acetate)
One IU of Vitamin A is equivalent to the activity of 0.3 mcg of
all-trans-retinol
ATC code: Vitamins – A11
Nutricorp International
4025 Rhodes Drive
Windsor, Ontario
N8W 5B5
Date of Preparation:
April 5, 2016
Submission Control No: 167923
_ _
_ _
_Page 2 of 34_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................4
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................7
OVERDOSAGE
..................................................................................................................8
ACTION AND CLINICAL PHARMACOLOGY
..............................................................9
STORAGE AND STABILITY
..........................................................................................12
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................12
PART II: SCIENTIFIC INFORMATION
...............................................................................14
PHARMACEUTICAL INFORMATION
.......................................................